MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacig.2024.100234

Медицинская библиотека · The journal of allergy and clinical immunology. Global · 2024

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency.

Zhang Anna M, Elmoursi Ahmed, DiGiacomo Daniel V, Zhou Baijun, Tandon Megha, Hong Joseph S, Yang Nancy J, Ong Mei-Sing, Dighe Anand S, Berrios Cristhian, Poznansky Mark C, Iafrate Anthony J, Naranbhai Vivek, Balazs Alejandro, Pillai Shiv, Farmer Jocelyn R, Barmettler Sara

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Patients with predominantly antibody deficiency (PAD) have lower anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2-dose SARS-CoV-2 vaccination than healthy controls do; however, the anti-spike antibody responses and neutralization function in patients with PAD following subsequent immunizations remain understudied.

OBJECTIVE

We sought to characterize anti-spike antibody responses in adults with PAD over the course of 5 SARS-CoV-2 vaccine doses and identify diagnostic and immunophenotypic risk factors for low antibody response.

METHODS

We evaluated anti-spike antibody levels in 117 adult patients with PAD and 192 adult healthy controls following a maximum of 5 SARS-CoV-2 immunizations. We assessed neutralization of the SARS-CoV-2 wild-type strain and the Omicron BA.5 variant and analyzed infection outcomes.

RESULTS

The patients with PAD had significantly lower mean anti-spike antibody levels after 3 SARS-CoV-2 vaccine doses than the healthy controls did (1,439.1 vs 21,890.4 U/mL [P < .0001]). Adults with secondary PAD, severe primary PAD, and high-risk immunophenotypes had lower mean anti-spike antibody levels following vaccine doses 2, 3, and/or 4 but not following vaccine dose 5. Compared with patients with mild and moderate PAD, patients with severe PAD had a higher rate of increase in anti-spike antibody levels over 5 immunizations. A strong positive correlation was observed between anti-spike antibody levels and neutralization of both the SARS-CoV-2 wild-type strain and the Omicron BA.5 variant. Most infections were managed on an outpatient basis.

CONCLUSIONS

In all of the patients with PAD, anti-spike antibody levels increased with successive SARS-CoV-2 immunizations and were correlated with neutralization of both the SARS-CoV-2 wild-type strain and the Omicron BA.5 variant. Secondary PAD, severe primary PAD, and high-risk immunophenotypes were correlated with lower mean anti-spike antibody levels following vaccine doses 2 through 4. Patients with severe PAD had the highest rate of increase in anti-spike antibody levels over 5 immunizations. These data suggest a clinical benefit to sequential SARS-CoV-2 immunizations, particularly among high-risk patients with PAD.

Для цитирования: Zhang Anna M, Elmoursi Ahmed, DiGiacomo Daniel V, Zhou Baijun, Tandon Megha, Hong Joseph S, Yang Nancy J, Ong Mei-Sing, Dighe Anand S, Berrios Cristhian, Poznansky Mark C, Iafrate Anthony J, Naranbhai Vivek, Balazs Alejandro, Pillai Shiv, Farmer Jocelyn R, Barmettler Sara. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency.. The journal of allergy and clinical immunology. Global. 2024. DOI: 10.1016/j.jacig.2024.100234.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.